During the past decade, Kurume University School of Medicine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kurume University School of Medicine" #1 sponsor was "Japan Rhabdomyosarcoma Study Group" with 2 trials, followed by "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "Kurume University" with 1 trials sponsored, "National Cancer Center Hospital East" with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kurume University School of Medicine" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator, "Japan Agency for Medical Research and Development" with 1 trials as a collaborator and "Japan Clinical Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kurume University School of Medicine" are "Colorectal Cancer" (2 trials), "Sarcoma" (2 trials), "Asthma" (1 trials), "Esophageal Cancer" (1 trials) and "Posttraumatic Stress Disorder" (1 trials). Many other conditions were trialed in "Kurume University School of Medicine" in a lesser frequency.

Most popular intervention types in "Kurume University School of Medicine" are "Drug" (8 trials), "Radiation" (3 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "UFT adjuvant chemotherapy" (2 trials), "cyclophosphamide" (2 trials), "dactinomycin" (2 trials), "radiation therapy" (2 trials) and "vincristine sulfate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kurume University School of Medicine" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Kurume University School of Medicine". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Kurume University School of Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kurume University School of Medicine, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".